FDA grants accelerated approval to zanidatamab-hrii
6 days ago · On November 20, 2024, the FDA granted accelerated approval to zanidatamab-hrii (Ziihera, Jazz Pharmaceuticals, Inc.), a bispecific HER2-directed antibody, for previously treated, unresectable or ...
OFF
Jazz And Zymeworks Announce FDA Approval Of Cancer Therapy …
2 days from now
Zymeworks (NASDAQ:ZYME), Jazz’s (NASDAQ:JAZZ) licensing partner for Ziihera (zanidatamab-hrii) for regions including the U.S., is set to receive a $50M milestone payment …
msn.com
OFF
FDA Grants U.S. Approval Of Ziihera® (zanidatamab-hrii) For The ...
2 days from now
5 days ago · $25M milestone payment to be received from Jazz Pharmaceuticals in relation to the FDA approval; Zymeworks remains eligible for up to $500M in regulatory milestones …
nasdaq.com
OFF
FDA Approves Ziihera For HER2-Positive Biliary Tract Cancer
2 days from now
5 days ago · Zymeworks will receive a $25 million milestone payment from Jazz after the FDA's ruling; further possible regulatory milestone payments up to $500 million and commercial …
yahoo.com
OFF
Jazz Gets First FDA Nod For HER2 Bispecific Ziihera
2 days from now
4 days ago · Jazz Pharma has claimed FDA approval for its HER2-directed ... and $1.76 billion in potential milestones laid out in Jazz's licensing deal for the drug with Zymeworks at the end of …
pharmaphorum.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
